MacManus, M. P., Seymour, J. F., Tsang, H., Fisher, R., Keane, C., Sabdia, M. B., . . . Tobin, J. W. Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphomaResearch in context. Elsevier.
Chicago Style (17th ed.) CitationMacManus, Michael P., et al. Adjuvant Rituximab and Elevated Intratumoural CD8 Expression Are Associated with Sustained Disease Control After Radiotherapy in a Randomised Trial of Systemic Therapy in Early-stage Follicular LymphomaResearch in Context. Elsevier.
MLA (9th ed.) CitationMacManus, Michael P., et al. Adjuvant Rituximab and Elevated Intratumoural CD8 Expression Are Associated with Sustained Disease Control After Radiotherapy in a Randomised Trial of Systemic Therapy in Early-stage Follicular LymphomaResearch in Context. Elsevier.